Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picosecond alexandrite laser plus rose-derived exosomes for melasma
TCTR20250722002Phase 4Not yet recruiting
- Sponsor
- N/A
- Start
- Jul 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in melasma (2 arms), sponsored by N/A. Primary endpoint: Modified Melasma Area and Severity Index. Planned start Jul 2025; status: not yet recruiting.
02
Conditions
melasma
Beyond the preview
Go deeper on TCTR20250722002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250722002.